HC
H&F Corporate Investors X, Ltd. 13F Filings Explorer
H&F Corporate Investors X, Ltd.CIK: 0001901930
Concentrated strategyLong-term holder
Total reported value
$3.8B
Reporting period: 2026-03-31 · Number of holdings: 1
H&F Corporate Investors X, Ltd. disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $3.8B and a quarterly turnover rate of 8.3%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "H"
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 8.26
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 2
- Sizing Uniformity
- —
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged MDLN
-13.1% -$331.5M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MDLN | Medline Inc-cl A | Stock-Other | 100.00% | — | -13.10% |
Portfolio Performance
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 0% of reported portfolio value with available pricing
- Stdev
- —
- Beta
- —
- Alpha
- —
- Max Drawdown
- —
- Annualized Perf
- —
- Batting Avg vs S&P
- —
- Sortino
- —
- Stutzer
- —
- Treynor
- —
- Sterling
- —
- Calmar
- —
- Information Ratio
- —
- Tracking Error
- —
- Stdev Down
- —
- Winning Months %
- —
- Losing Months %
- —
- Best 12 Months
- —
- Worst 12 Months
- —
- Efficiency Ratio
- —
- Sharpe
- —
- Stdev Sectors
- —
- Skewness
- —
- Kurtosis
- —
- Upside Potential
- —
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | $3.8B | 8 | |
| 2025-12-31 | 1 | $4.2B | 100 | |
| 2025-09-30 | 1 | — | 0 | |
| 2025-06-30 | 1 | — | 0 | |
| 2025-03-31 | 1 | — | 0 | |
| 2024-12-31 | 1 | — | 0 | |
| 2024-09-30 | 1 | — | 0 | |
| 2024-06-30 | 1 | — | 0 | |
| 2024-03-31 | 1 | — | 0 | |
| 2023-12-31 | 1 | $2.0B | 0 | |
| 2023-09-30 | 1 | $1.9B | 0 | |
| 2023-06-30 | 1 | $1.4B | 0 | |
| 2023-03-31 | 1 | $1.2B | 0 | |
| 2022-12-31 | 1 | $1.1B | 0 | |
| 2022-09-30 | 1 | $962.5M | 0 | |
| 2022-06-30 | 1 | $1.1B | 0 | |
| 2022-03-31 | 1 | $1.8B | 0 |
Holding changes this quarter
H&F Corporate Investors X, Ltd.'s most significant position changes for 2026-03-31: Trim: Medline Inc-cl A (MDLN) — shares -13.10%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MDLN | Medline Inc-cl A | — | -13.10% | Trim |
Filing History
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-11 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-12 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-12 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-13 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-12 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-13 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-13 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-04 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-01-30 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-09 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
FAQ
What is H&F Corporate Investors X, Ltd. and what type of investor is it?
H&F Corporate Investors X, Ltd. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $3.8B, spread across 1 disclosed positions.
What are H&F Corporate Investors X, Ltd.'s largest equity positions?
Based on the latest 13F filing, H&F Corporate Investors X, Ltd.'s top holdings by market value are:
1. Medline Inc-cl A (MDLN) — $3.8B (100.0%)
What changes did H&F Corporate Investors X, Ltd. make in its most recent portfolio filing?
In the latest quarter, H&F Corporate Investors X, Ltd. took a more defensive posture — trimming 1 positions and completely exiting 0 holdings. The largest of these moves: Trim: Medline Inc-cl A (MDLN) — shares -13.10%
What sectors does H&F Corporate Investors X, Ltd. focus on?
Sector breakdown data is not yet available for H&F Corporate Investors X, Ltd.. Check back after the next 13F processing cycle.
Peer Institutions
Institutions with a similar AUM
TR
Tower Research Capital LLC (TRC)
CIK 0001533421
Total reported value
$3.8B
6,440 stks
2026-03-31
Concentration2.8
Portfolio Stability84.5
Sector conviction46.9
AUM within 0.0% of this institution
View detail
FH
First Horizon Advisors, Inc.
CIK 0001588539
Total reported value
$3.8B
4,799 stks
2025-06-30
Stale — no recent filing
Concentration3.6
Portfolio Stability0.0
Sector conviction52.3
AUM within 0.0% of this institution
View detail
DW
Destination Wealth Management
CIK 0001278573
Total reported value
$3.9B
342 stks
2026-03-31
Concentration6.8
Portfolio Stability11.1
Sector conviction50.2
AUM within 0.1% of this institution
View detail
Similar Holdings Style
Institutions with overlapping top holdings
Carlyle Group Inc.
CIK 0001527166
Total reported value
$10.6B
20 stks
2026-03-31
Concentration100.0
Portfolio Stability24.4
Sector conviction100.0
1 of the top 5 holdings overlap, including Medline Inc-cl A
View detail
LP
Lexington Partners L.P.
CIK 0001621157
Total reported value
$366.4M
3 stks
2026-03-31
Concentration100.0
Portfolio Stability9.8
Sector conviction100.0
1 of the top 5 holdings overlap, including Medline Inc-cl A
View detail
MI
Monashee Investment Management LLC
CIK 0001627608
Total reported value
$183.8M
45 stks
2026-03-31
Concentration16.8
Portfolio Stability100.0
Sector conviction83.9
1 of the top 5 holdings overlap, including Medline Inc-cl A
View detail